Teratogenic response to arsenite during neurulation: relative sensitivities of C57BL/6J and SWV/Fnn mice and impact of the splotch allele
- PMID: 10496681
- DOI: 10.1093/toxsci/51.1.98
Teratogenic response to arsenite during neurulation: relative sensitivities of C57BL/6J and SWV/Fnn mice and impact of the splotch allele
Abstract
Arsenic is an environmental contaminant that induces congenital malformations, primarily neural tube defects, in laboratory animals, and it may contribute to human birth defects. The acute doses of arsenicals required to elicit teratogenesis in outbred strains of mice, however, are orders of magnitude higher than those to which humans are exposed environmentally. In order to examine interactions between arsenite administration during neurulation and murine genotype, the present study compares two inbred mouse strains, establishes a teratogenic dose of arsenite, and evaluates the effect of the splotch mutation on arsenic-induced teratogenesis. SWV/Fnn or C57BL/6J females were injected intraperitoneally with sodium arsenite (10 mg/kg) on days 6.5, 7.0, 7.5, 8.0, 8.5, or 9.0 of gestation. A dose-response study was carried out in the C57BL/6J strain, and the effect of the splotch mutation, introduced via the male (C57BL/6J Sp/+), was assessed. Fetuses were examined for external, visceral, and skeletal malformations. Fetuses from crosses of C57BL/6J females with C57BL/6J Sp/+ males were genotyped by PCR. Ten-mg/kg sodium arsenite was teratogenic in nearly 50% of C57BL/6J fetuses, and the C57BL/6J strain was significantly more sensitive to arsenite-induced embryo-lethality and teratogenicity than the SWV/Fnn strain. The spectrum of malformations produced was dependent on the gestational time point of arsenite administration. Introduction of the splotch allele significantly increased neural tube defects and other specific malformations. This result demonstrates that a mutation in a single gene can increase sensitivity to arsenic-induced birth defects. This murine study examines the interaction between arsenite-induced teratogenicity and genotype.
Similar articles
-
Effect of arsenite, maternal age, and embryonic sex on spina bifida, exencephaly, and resorption rates in the splotch mouse.Birth Defects Res A Clin Mol Teratol. 2003 Apr;67(4):231-9. doi: 10.1002/bdra.10006. Birth Defects Res A Clin Mol Teratol. 2003. PMID: 12854658
-
Diabetic embryopathy in C57BL/6J mice. Altered fetal sex ratio and impact of the splotch allele.Diabetes. 2001 May;50(5):1193-9. doi: 10.2337/diabetes.50.5.1193. Diabetes. 2001. PMID: 11334426
-
Effects of folate supplementation on the risk of spontaneous and induced neural tube defects in Splotch mice.Teratology. 2002 Feb;65(2):63-9. doi: 10.1002/tera.10019. Teratology. 2002. PMID: 11857507
-
Developmental and reproductive toxicity of inorganic arsenic: animal studies and human concerns.J Toxicol Environ Health B Crit Rev. 1998 Jul-Sep;1(3):199-241. doi: 10.1080/10937409809524552. J Toxicol Environ Health B Crit Rev. 1998. PMID: 9644328 Review.
-
Immunoteratology: I. MHC involvement in the embryo response to teratogens in mice.Am J Reprod Immunol. 1995 Nov;34(5):288-98. doi: 10.1111/j.1600-0897.1995.tb00955.x. Am J Reprod Immunol. 1995. PMID: 8595128 Review.
Cited by
-
Unraveling the multifaceted resilience of arsenic resistant bacterium Deinococcus indicus.Front Microbiol. 2023 Aug 24;14:1240798. doi: 10.3389/fmicb.2023.1240798. eCollection 2023. Front Microbiol. 2023. PMID: 37692390 Free PMC article.
-
Cadmium-induced differential toxicogenomic response in resistant and sensitive mouse strains undergoing neurulation.Toxicol Sci. 2009 Jan;107(1):206-19. doi: 10.1093/toxsci/kfn221. Epub 2008 Oct 29. Toxicol Sci. 2009. PMID: 18974090 Free PMC article.
-
Arsenic hampered embryonic development: An in vivo study using local Bangladeshi Danio rerio model.Toxicol Rep. 2020 Jan 11;7:155-161. doi: 10.1016/j.toxrep.2019.12.009. eCollection 2020. Toxicol Rep. 2020. PMID: 31993334 Free PMC article.
-
Arsenic- and cadmium-induced toxicogenomic response in mouse embryos undergoing neurulation.Toxicol Appl Pharmacol. 2011 Jan 15;250(2):117-29. doi: 10.1016/j.taap.2010.09.018. Epub 2010 Sep 29. Toxicol Appl Pharmacol. 2011. PMID: 20883709 Free PMC article.
-
Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis.J Clin Invest. 2015 Aug 3;125(8):2935-51. doi: 10.1172/JCI74929. Epub 2015 Jul 20. J Clin Invest. 2015. PMID: 26193634 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical